Status:
COMPLETED
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
Lead Sponsor:
Allergan
Conditions:
Facial Rhytides
Crow's Feet Lines
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully co...
Eligibility Criteria
Inclusion
- Successfully completed Study 191622-099
Exclusion
- Known immunization or hypersensitivity to botulinum toxin of any serotype
- Anticipated need for treatment with botulinum toxin of any serotype during the study (except for study treatment)
- Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis
- Anticipated need for surgery or hospitalization during the study
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
684 Patients enrolled
Trial Details
Trial ID
NCT01224015
Start Date
May 1 2011
End Date
February 1 2012
Last Update
February 25 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Newport Beach, California, United States
2
Vancouver, British Columbia, Canada
3
Antibes, France
4
Berlin, Germany